Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 50750 / DOSAGE - INJECTABLE;INJECTION - EQ 60MG BASE/ML;EQ 7.5MG BASE/ML
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| PIPERACILLIN SODIUM(UNII: M98T69Q7HP) (PIPERACILLIN ANHYDROUS - UNII:9I628532GX) | PIPERACILLIN ANHYDROUS | 4g in 100 | 3g in 50 | 2g in 50 |
| TAZOBACTAM SODIUM(UNII: UXA545ABTT) (TAZOBACTAM - UNII:SE10G96M8W) | TAZOBACTAM | 500mg in 100 | 375mg in 50 | 250mg in 50 |
Inactive Ingredients
| Ingredient Name | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. |
|---|---|---|
| DEXTROSE MONOHYDRATE(LX22YL083G) | ||
| EDETATE DISODIUM(7FLD91C86K) | ||
| HYDROCHLORIC ACID(QTT17582CB) | ||
| SODIUM BICARBONATE(8MDF5V39QO) | ||
| SODIUM CITRATE(1Q73Q2JULR) | ||
| SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR) | ||
| WATER(059QF0KO0R) |
